申请人:Pfizer Inc.
公开号:US06610707B1
公开(公告)日:2003-08-26
Compounds of the formula:
wherein R1, Y, W, A and R2 are as defined above are inhibitors of rotamase enzymes in particular FKBP-12 and FKBP-52. The compounds therefore moderate neuronal regeneration and outgrowth and can be used for treating neurological disorders arising from neurodegenerative diseases and nerve damage.
该式化合物:其中R1、Y、W、A和R2如上所定义,是特定的FKBP-12和FKBP-52的旋转酶酶抑制剂。因此,这些化合物可以调节神经再生和生长,并可用于治疗由神经退行性疾病和神经损伤引起的神经系统疾病。